List of Excipients in API buprenorphine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing buprenorphine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | METHYLPYRROLIDONE | |
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | POLY(DL-LACTIC-CO-GLYCOLIC ACID) | |
| Rhodes Pharmaceuticals LP | BUPRENORPHINE | buprenorphine | 42858-750 | ETHYL LEVULINATE | |
| Rhodes Pharmaceuticals LP | BUPRENORPHINE | buprenorphine | 42858-750 | OLEYL OLEATE | |
| Rhodes Pharmaceuticals LP | BUPRENORPHINE | buprenorphine | 42858-750 | POVIDONE | |
| Lake Erie Medical DBA Quality Care Products LLC | BUPRENORPHINE | buprenorphine | 55700-579 | ETHYL LEVULINATE | |
| Lake Erie Medical DBA Quality Care Products LLC | BUPRENORPHINE | buprenorphine | 55700-579 | OLEYL OLEATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing buprenorphine
Detailed excipient profiles for buprenorphine
Excipient focus: .ALPHA.-TOCOPHEROL
buprenorphine drug variants containing .ALPHA.-TOCOPHEROL
buprenorphine drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine drug variants containing .ALPHA.-TOCOPHEROL ACETATE
buprenorphine drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
Excipient focus: ACESULFAME POTASSIUM
buprenorphine drug variants containing ACESULFAME POTASSIUM
buprenorphine drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ALCOHOL
buprenorphine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
buprenorphine drug variants containing ALUMINUM OXIDE
buprenorphine drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
buprenorphine drug variants containing AMMONIA
buprenorphine drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine drug variants containing ANHYDROUS CITRIC ACID
buprenorphine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS DEXTROSE
buprenorphine drug variants containing ANHYDROUS DEXTROSE
buprenorphine drug variants not containing ANHYDROUS DEXTROSE
Excipient focus: ANHYDROUS LACTOSE
buprenorphine drug variants containing ANHYDROUS LACTOSE
buprenorphine drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
buprenorphine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing BUTYL ALCOHOL
Excipient focus: BUTYLATED HYDROXYANISOLE
buprenorphine drug variants containing BUTYLATED HYDROXYANISOLE
buprenorphine drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
buprenorphine drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
buprenorphine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| Contract Pharmacy Services-PA | buprenorphine hydrochloride sublingual | 67046-996 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID ACETATE
buprenorphine drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1378 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CITRIC ACID ACETATE
Excipient focus: CITRIC ACID MONOHYDRATE
buprenorphine drug variants containing CITRIC ACID MONOHYDRATE
buprenorphine drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CORN SYRUP
buprenorphine drug variants containing CORN SYRUP
buprenorphine drug variants not containing CORN SYRUP
Excipient focus: CROSCARMELLOSE SODIUM
buprenorphine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
buprenorphine drug variants containing CROSPOVIDONE
buprenorphine drug variants not containing CROSPOVIDONE
Excipient focus: DEXTROSE
buprenorphine drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | buprenorphine hydrochloride | 0517-0725 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing DEXTROSE
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
buprenorphine drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing DIBASIC POTASSIUM PHOSPHATE
Excipient focus: ETHYL LEVULINATE
buprenorphine drug variants containing ETHYL LEVULINATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| Lake Erie Medical DBA Quality Care Products LLC | buprenorphine | 55700-579 |
| Purdue Pharma LP | buprenorphine | 59011-751 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ETHYL LEVULINATE
Excipient focus: FD&C BLUE NO. 1
buprenorphine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
buprenorphine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1378 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
buprenorphine drug variants containing FD&C YELLOW NO. 6
buprenorphine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine drug variants containing FERRIC OXIDE YELLOW
buprenorphine drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
buprenorphine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERYL DIOLEATE
buprenorphine drug variants containing GLYCERYL DIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing GLYCERYL DIOLEATE
Excipient focus: HYDROCHLORIC ACID
buprenorphine drug variants containing HYDROCHLORIC ACID
buprenorphine drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine drug variants containing HYDROXYETHYL CELLULOSE
buprenorphine drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine drug variants containing HYDROXYPROPYL CELLULOSE
buprenorphine drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE 2910
buprenorphine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
buprenorphine drug variants containing HYPROMELLOSES
buprenorphine drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
buprenorphine drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
buprenorphine drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| bryant ranch prepack | buprenorphine hydrochloride | 63629-4092 |
| Physicians Total Care Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54868-5750 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine drug variants containing LACTOSE MONOHYDRATE
buprenorphine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
buprenorphine drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LECITHIN, SOYBEAN
Excipient focus: LEVULINIC ACID
buprenorphine drug variants containing LEVULINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Alvogen Inc | buprenorphine | 47781-406 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine | 50742-372 |
| Amneal Pharmaceuticals NY LLC | buprenorphine | 69238-1202 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LEVULINIC ACID
Excipient focus: MAGNESIUM STEARATE
buprenorphine drug variants containing MAGNESIUM STEARATE
buprenorphine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTITOL
buprenorphine drug variants containing MALTITOL
buprenorphine drug variants not containing MALTITOL
Excipient focus: MALTODEXTRIN
buprenorphine drug variants containing MALTODEXTRIN
buprenorphine drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
buprenorphine drug variants containing MANNITOL
buprenorphine drug variants not containing MANNITOL
Excipient focus: MENTHOL
buprenorphine drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MENTHOL
Excipient focus: METHYLPARABEN
buprenorphine drug variants containing METHYLPARABEN
buprenorphine drug variants not containing METHYLPARABEN
Excipient focus: METHYLPYRROLIDONE
buprenorphine drug variants containing METHYLPYRROLIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing METHYLPYRROLIDONE
Excipient focus: OLEYL OLEATE
buprenorphine drug variants containing OLEYL OLEATE
buprenorphine drug variants not containing OLEYL OLEATE
Excipient focus: PEPPERMINT OIL
buprenorphine drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine hydrochloride | 59385-021 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing PEPPERMINT OIL
Excipient focus: POLY(DL-LACTIC-CO-GLYCOLIC ACID)
buprenorphine drug variants containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
Excipient focus: POLYCARBOPHIL
buprenorphine drug variants containing POLYCARBOPHIL
buprenorphine drug variants not containing POLYCARBOPHIL
Excipient focus: POLYETHYLENE GLYCOL
buprenorphine drug variants containing POLYETHYLENE GLYCOL
buprenorphine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 8000
buprenorphine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
buprenorphine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Aidarex Pharmaceuticals LLC | buprenorphine hydrochloride, naloxone hydrochloride | 53217-328 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYETHYLENE OXIDE 100000
buprenorphine drug variants containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 100000
Excipient focus: POLYETHYLENE OXIDE 1000000
buprenorphine drug variants containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 1000000
Excipient focus: POLYETHYLENE OXIDE 200000
buprenorphine drug variants containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 200000
Excipient focus: POLYETHYLENE OXIDE 2000000
buprenorphine drug variants containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 2000000
Excipient focus: POLYETHYLENE OXIDE 900000
buprenorphine drug variants containing POLYETHYLENE OXIDE 900000
buprenorphine drug variants not containing POLYETHYLENE OXIDE 900000
Excipient focus: POTASSIUM HYDROXIDE
buprenorphine drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
buprenorphine drug variants containing POVIDONE
buprenorphine drug variants not containing POVIDONE
Excipient focus: POVIDONE K29/32
buprenorphine drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
buprenorphine drug variants containing POVIDONE K30
buprenorphine drug variants not containing POVIDONE K30
Excipient focus: POVIDONE K90
buprenorphine drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine | 47781-406 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE K90
Excipient focus: PROPYLENE GLYCOL
buprenorphine drug variants containing PROPYLENE GLYCOL
buprenorphine drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
buprenorphine drug variants containing PROPYLPARABEN
buprenorphine drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
buprenorphine drug variants containing SACCHARIN SODIUM
buprenorphine drug variants not containing SACCHARIN SODIUM
Excipient focus: SHELLAC
buprenorphine drug variants containing SHELLAC
buprenorphine drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
buprenorphine drug variants containing SILICON DIOXIDE
buprenorphine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
buprenorphine drug variants containing SODIUM BENZOATE
buprenorphine drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CITRATE
buprenorphine drug variants containing SODIUM CITRATE
buprenorphine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
buprenorphine drug variants containing SODIUM HYDROXIDE
buprenorphine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM METABISULFITE
buprenorphine drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| Apotex Corp | buprenorphine and naloxone | 60505-7053 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
buprenorphine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Excipient focus: SODIUM STEARYL FUMARATE
buprenorphine drug variants containing SODIUM STEARYL FUMARATE
buprenorphine drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
buprenorphine drug variants containing STARCH, CORN
buprenorphine drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
buprenorphine drug variants containing SUCRALOSE
buprenorphine drug variants not containing SUCRALOSE
Excipient focus: TITANIUM DIOXIDE
buprenorphine drug variants containing TITANIUM DIOXIDE
buprenorphine drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine drug variants containing TRISODIUM CITRATE DIHYDRATE
buprenorphine drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
buprenorphine drug variants containing WATER
buprenorphine drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
